Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Medical City Dallas located at 7777 Forest Ln, Dallas, TX, 75230 & includes data from NPIs 1487606596, 1689628984
Dexur analyzed Q2 2017 (April to June 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Medical City Dallas compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,449 | 1,388 | ||||||||||
| Surgical | 504 | 489 | ||||||||||
| Non Surgical | 945 | 899 | ||||||||||
| Cardiovascular | 268 | 259 | ||||||||||
| General Medicine | 181 | 168 | ||||||||||
| Orthopedics | 172 | 170 | ||||||||||
| General Surgery | 153 | 143 | ||||||||||
| Urology | 123 | 122 | ||||||||||
| Gastroenterology & Endocrinology | 122 | 118 | ||||||||||
| Oncology & Hematology | 121 | 116 | ||||||||||
| Pulmonology | 111 | 103 | ||||||||||
| Neurology | 100 | 92 | ||||||||||
| Obstetrics & Gynecology | 33 | 32 | ||||||||||
| Colorectal | 22 | 22 | ||||||||||
| Spine | 15 | 15 | ||||||||||
| Psychiatry & Mental Disorders | 11 | 11 |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| Coronary Bypass |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Signs And Symptoms | ||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Respiratory System O.R. Procedures | ||||||||||||
| DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| Extracranial Procedures |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney Transplant | ||||||||||||
| DRG 652: KIDNEY TRANSPLANT |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| Other Digestive System Diagnoses |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Red Blood Cell Disorders | ||||||||||||
| DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Lymphoma And Non-Acute Leukemia | ||||||||||||
| Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support | ||||||||||||
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
| Respiratory Infections And Inflammations |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Texas Total Hospitalizations (Apr 2017 to Jun 2017) | Texas Total Hospitalizations After Exclusion | Texas Total Users | Texas SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |